AG
ONCE

Aperio Group’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

Aperio Group’s Portfolio ONCE Stock Details ONCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-11,014
Closed -$1.07M – 2369
2019
Q3 		$1.07M Buy
11,014
+3,352
+44% +$336K ﹤0.01% 1360
2019
Q2 		$784K Buy
7,662
+1,198
+19% +$129K ﹤0.01% 1526
2019
Q1 		$736K Sell
6,464
-460
-7% -$33.8K ﹤0.01% 1528
2018
Q4 		$271K Buy
6,924
+1,007
+17% +$43.7K ﹤0.01% 1992
2018
Q3 		$323K Buy
5,917
+374
+7% +$25.6K ﹤0.01% 1975
2018
Q2 		$459K Buy
5,543
+1,056
+24% +$81.5K ﹤0.01% 1778
2018
Q1 		$299K Buy
4,487
+515
+13% +$29.7K ﹤0.01% 1957
2017
Q4 		$204K Buy
3,972
+898
+29% +$64.5K ﹤0.01% 2136
2017
Q3 		$274K Buy
+3,074
New +$233K ﹤0.01% 1967

Aperio Group's ONCE Position: Q4 2019 in Review

Aperio Group sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q4 2019, closing a stake of 11,014 shares — an estimated $1.07M sold.

Aperio Group first reported a position in ONCE in Q3 2017 and held it in 9 quarters. The position peaked at $1.07M in Q3 2019. 0 funds tracked by Wall St. Rank hold ONCE as of Q4 2019.

  • Aperio Group reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
  • Aperio Group sold 11,014 Spark Therapeutics, Inc. Common Stock shares in Q4 2019, an estimated $1.07M.
  • Aperio Group first reported a position in Spark Therapeutics, Inc. Common Stock in Q3 2017 and held it in 9 quarters.
  • Aperio Group's Spark Therapeutics, Inc. Common Stock position peaked at $1.07M in Q3 2019.
  • 0 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q4 2019.

Based on Aperio Group's 13F filing for Q4 2019, filed 13 Feb 2020.